LYRAGBP

Lyra Therapeutics, Inc.

A maker of long-acting drug-delivery devices for the ears, nose, and throat, Lyra Therapeutics developed bioresorbable nasal implants that slowly release an anti-inflammatory steroid directly into the sinuses to treat chronic rhinosinusitis. The company was founded in 2005 under a different name (WMR Biomedical) by celebrated scientists including drug-delivery pioneer Robert Langer, and it renamed itself Lyra in 2018 — roughly a decade before it halted work on its lead implant in early 2026.

Recent Activity

Show $

2021Q4

1 sell

ArrowMark PartnersEXIT

-139.2K shares

ArrowMark PartnersEXIT

-139.2K shares

2021Q1

1 sell

ArrowMark PartnersTRIM

-636.7K shares(-82.1%)

ArrowMark PartnersTRIM

-636.7K shares(-82.1%)

Loading more activity...